31 – 39 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2010
-
Mark
ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset.
(
- Contribution to journal › Article
- 2009
-
Mark
ZnT8, GAD 65 and IA-2 autoantibodies in type 1 diabetes children at diagnosis and 3-5 years after the diagnosis, stratified for residual beta cell function
(
- Contribution to journal › Published meeting abstract
-
Mark
Strong association between SLC30A8 gene variant and ZnT8 autoantibody specificity during disease progression in two independent cohorts of children with newly diagnosed type 1 diabetes
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.29-29(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
(
- Contribution to journal › Article
- 2007
-
Mark
A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
(
- Contribution to journal › Article
- 2006
-
Mark
Studies of the role of complement factor H in hemolytic uremic syndrome
2006) In Journal of thrombosis and haemostasis, and Kidney International(
- Thesis › Doctoral thesis (compilation)
-
Mark
Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Platelet activation in hemolytic uremic syndrome.
(
- Contribution to journal › Scientific review
- 2005
-
Mark
Factor H binds to washed human platelets
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »